# Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.

> **NCT01929486** · PHASE1 · UNKNOWN · sponsor: **Aichi Medical University** · enrollment: 58 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** Mogamulizumab

## Key facts

- **NCT ID:** NCT01929486
- **Lead sponsor:** Aichi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2016-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929486, "Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01929486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*